Comments on: A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY OF FAB122 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS. ADOREXT

Comments on: A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY OF FAB122 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS. ADOREXT https://ibima.eu/en/a-multicenter-open-label-extension-study-to-investigate-the-long-term-safety-of-fab122-in-patients-with-amyotrophic-lateral-sclerosis-adorext/ Wed, 03 Jul 2024 12:27:29 +0000 hourly 1 https://wordpress.org/?v=6.6.1